Are peptides legal in your state?
A sourced, cited answer for every US state. Each page leads with the verdict, then the regulatory framework, a compound-by-compound breakdown, and the official sources behind every claim.
Verdicts reflect how each state layers its own rules on top of federal FDA law. Every state page cites official sources and shows when it was last researched.
West13 states
Midwest12 states
South16 states
Northeast9 states
Reviewed quarterly against FDA guidance, state pharmacy-board rules, and published enforcement actions. Select a state for the full sourced breakdown.
More from Peptides.io
- GLP-1 Treatment Gap Index →Our analysis of where Medicaid access to GLP-1s falls shortest, by state
- The Gray-Market Peptide Report →Our analysis of how unapproved peptides are sold and marketed
- Original research from Peptides.io →Data reports we produce ourselves
Related data
- FDA drug shortage tracker →Which peptide drugs are in shortage now, with the FDA-stated cause
- Which peptides are FDA-approved →Approval status for every peptide, from Drugs@FDA
- When peptide drugs go generic →Patent and exclusivity expiry dates from the FDA Orange Book
- Which peptides have clinical evidence →Registered clinical trial counts from ClinicalTrials.gov
- Peptide legality by country →A sourced verdict for 50 countries
